News Release

National Jewish Health announces call for abstracts for Respiratory Disease Young Investigators’ Forum

Meeting Announcement

National Jewish Health

DENVER — (MAY 12, 2022) – National Jewish Health will host the 18th Annual Respiratory Disease Young Investigators’ Forum October 6-9, 2022, in Denver. Young physician investigators in pulmonology, allergy and immunology, pediatric, and related programs interested in a career in research are encouraged to submit basic science or clinical research abstracts by Friday, June 17, 2022, to be considered for participation.

The goal of the Respiratory Disease Young Investigators’ Forum is to increase the number of physician-scientists through a program for fellows and early career faculty that includes mentoring, peer networking, coaching, scientific presentation skills, education and encouragement.

The Forum provides the opportunity to present research to a panel of national experts in respiratory medicine who serve as mentors and real-world examples of physician-scientists who have had an impact on respiratory medicine through their research.

The three-day program will include mentoring and networking opportunities with peers and experts, and formal presentations of research with pediatric or adult populations in asthma, bronchiectasis, COPD, COVID-19, cystic fibrosis, interstitial lung disease, pulmonary fibrosis, sleep disorders and other respiratory diseases.

“As a former Young Investigator and former Research Advisor for the Young Investigators’ Forum, I am honored to return as one of the program chairs this year. This program is more important than ever as COVID has interrupted research in many areas to focus on clinical patient care. COVID has also really driven home for all of us in medicine how very crucial the physician-scientist’s role is,” said Program Co-Chair Jennifer Taylor-Cousar, MD, MSCS, ATSF.

Fellows and junior faculty in pulmonary, allergy and immunology, pediatric, and related programs are encouraged to apply. Thirty investigators will be selected and invited to present their research at the Forum based on the following criteria: scientific importance, quality of research, whether the research will enhance knowledge, whether the research answers a question, and overall presentation of the abstract. The top three presentations in basic science and clinical research will earn monetary awards.

“The National Jewish Health Young Investigators’ Forum was a phenomenal experience. It provided opportunities to receive scientific feedback from expert faculty and peers, as well as to network with both faculty members and other young physician-scientists from across the country. The presentations by expert faculty were especially helpful and included developing our reputation as early career scientists, guidance on funding opportunities, life-work balance, and incorporating diversity into our careers to achieve excellence,” said Matthew Moll, MD, MPH, 2021 First Place Clinical Research Winner from Brigham and Women’s Hospital in Boston. 

National Jewish Health, the nation’s leading respiratory hospital, is committed to developing the next generation of physician-scientists through the sponsorship of the Respiratory Disease Young Investigators’ Forum. This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

More information on abstract submission guidelines, the agenda, and program format can be found here:

National Jewish Health is the leading respiratory hospital in the nation. Founded 123 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit or the media resources page.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.